Chemosensitization and mobilization of AML/ALL/MDS with plerixafor (AMD 3100), a CXCR4 antagonist: A phase I study of plerixafor + cytarabine and etoposide in pediatric patients with acute leukemia and MDS Meeting Abstract

  

Authors:	Cooper, T. M.; Baker, S. D.; Direnzo, J.; Trippett, T. M.; Gore, L.; Narendran, A.; August, K. J.; Absalon, M. J.; Boklan, J.; Pollard, J.; Magoon, D.; Sison, E. A. R.; Brown, P.
Abstract Title:	Chemosensitization and mobilization of AML/ALL/MDS with plerixafor (AMD 3100), a CXCR4 antagonist: A phase I study of plerixafor + cytarabine and etoposide in pediatric patients with acute leukemia and MDS
Meeting Title:	55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	122
Issue:	21
Meeting Dates:	2013 Dec 7-10
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2013-11-15
Language:	English
ACCESSION:	WOS:000331385005392
PROVIDER:	wos
DOI:	10.1182/blood.V122.21.2680.2680
Notes:	Meeting Abstract: 2680 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/125664